What to Look for in Mattress Firm Earnings

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
What to Look for in Mattress Firm Earnings

© Thinkstock

Mattress Firm Holding Corp. (NASDAQ: MFRM) is set to report its fiscal first-quarter financial results after the markets close on Thursday. The consensus estimates from Thomson Reuters are calling for a net loss of $0.04 per share on $867.20 million in revenue. In the same period of the previous year, the company posted EPS of $0.33 and $562.55 million in revenue.

In the previous quarter, the company said that it expected to have a net loss of $0.07 per share to breakeven in the fiscal first quarter, compared to the consensus estimate of $0.30 EPS at that time. This discrepancy was mainly driven by the dilution from financing the Sleepy’s acquisition.

Separate from the previous earnings report in March, Mattress Firm announced that Ken Murphy has been appointed president and CEO and Steve Stagner will assume the role of executive chairman of Mattress Firm and chairman of the board of directors. The changes, which were effective immediately, represent part of a long-term succession plan for the organization and will allow for better division of responsibilities for the two executives.

[nativounit]

A few analysts weighed in on Mattress Firm prior to the earnings report:

  • Piper Jaffray reiterated a Neutral rating with a $35 price target.
  • Wedbush reiterated a Neutral rating with a $38 price target.
  • Citigroup has a Neutral rating.

So far in 2016, Mattress Firm has underperformed the broad markets, with the stock down 23%. Over the past 52 weeks, the stock is down 44%.

Shares of Mattress Firm traded at $34.30 on Thursday, with a consensus analyst price target of $44.56 and a 52-week trading range of $30.01 to $65.51.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618